Floatz logo

Bictegravir

Antiretroviral Treatment

José Antonio Mata MarínSmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

61 Active assets in the Antiretroviral Treatment cohort.

Asset / SponsorPhaseRating
Raltegravir
Helsinki University Central Hospital
Phase 4A
ZIDOVUDINE
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase 4BBB
Efavirenz
The Cleveland Clinic
Phase 4BBB
Abacavir
Germans Trias i Pujol Hospital
Phase 4BBB
Dolutegravir
Instituto Mexicano del Seguro Social
Phase 4BBB

View all 50 →

Same molecule, other indications

Bictegravir is also rated in:

abdominal obesity-metabolic syndromeDormant
B
Indicative ·
63 / 100
View asset →
Body Weight ChangesDormant
B
Indicative ·
60 / 100
View asset →
ARTDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →